Skip to content

What is Vigafen?: Differentiating Ketoprofen from Vigabatrin

3 min read

According to the Ethiopian Food and Drug Administration (EFDA), Vigafen is a brand name for the non-steroidal anti-inflammatory drug (NSAID) ketoprofen lysine salt, used to treat pain and inflammation. Due to its name, it is often confused with vigabatrin, a potent anti-epileptic medication associated with a serious risk of permanent vision loss.

Quick Summary

Vigafen is the NSAID ketoprofen, prescribed for pain and inflammatory conditions like arthritis. It is a completely different medication from vigabatrin, an anti-epileptic drug with a boxed warning for vision loss, despite their similar-sounding names.

Key Points

  • Active Ingredient: Vigafen contains ketoprofen lysine salt, an NSAID, not the anti-epileptic drug vigabatrin.

  • Therapeutic Purpose: It is used for pain, inflammation, and arthritis, while vigabatrin treats severe seizures.

  • Safety Profile: Vigafen has NSAID-related risks like GI bleeding, whereas vigabatrin has a boxed warning for permanent vision loss.

  • Source of Confusion: The similar-sounding name is a well-documented cause of potentially dangerous medication errors.

  • Consult a Professional: Always confirm the correct medication with a healthcare provider and understand its specific use and risks.

  • Mechanism of Action: Vigafen (ketoprofen) works by inhibiting COX enzymes to reduce prostaglandin production.

In This Article

Vigafen: A Brand Name for Ketoprofen

Vigafen is a brand-name medication, specifically a powder for oral solution, that contains the active ingredient ketoprofen lysine salt. Ketoprofen is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain and reduce inflammation and swelling caused by various conditions. Like other NSAIDs, it is available by prescription and should be used under the guidance of a healthcare professional.

How does ketoprofen work?

Ketoprofen's mechanism of action involves inhibiting enzymes known as cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). These enzymes are responsible for producing prostaglandins, which are compounds in the body that cause pain, fever, and inflammation. By blocking the production of these prostaglandins, ketoprofen reduces pain and inflammation.

Therapeutic uses of Vigafen

Vigafen (ketoprofen) is used for the symptomatic treatment of various painful and inflammatory conditions. Indications commonly include arthritic conditions like rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis, musculoskeletal pain such as post-traumatic inflammation, and other inflammatory issues like dental pain or menstrual cramps.

The Crucial Difference: Vigafen (Ketoprofen) vs. Vigabatrin

The similar names Vigafen and Vigabatrin pose a significant patient safety risk due to the drastically different natures of the two drugs. Vigabatrin is an anti-epileptic drug (AED) with serious warnings, including a risk of permanent vision loss, and is under a restricted distribution program (REMS) in the U.S.. Vigafen (ketoprofen), an anti-inflammatory medication, does not carry these specific neurological risks. Patients and caregivers must confirm they receive the correct medication.

Comparison Table: Vigafen (Ketoprofen) vs. Vigabatrin

Feature Vigafen (Ketoprofen) Vigabatrin (Brand names: Sabril, Vigafyde)
Active Ingredient Ketoprofen lysine salt Vigabatrin
Drug Class Non-steroidal Anti-inflammatory Drug (NSAID) Anti-epileptic Drug (AED)
Primary Uses Pain, inflammation, and arthritis Infantile spasms and refractory complex partial seizures
Major Safety Warning Increased risk of serious cardiovascular and gastrointestinal events Boxed Warning for Permanent Vision Loss
Distribution Regular prescription (regional) Restricted via a Risk Evaluation and Mitigation Strategy (REMS) program
Target Population Adults and sometimes children for pain/fever Specific pediatric patients for infantile spasms and adults for refractory seizures

Side effects and precautions of Vigafen (Ketoprofen)

Like all medications, Vigafen can cause side effects, and awareness is crucial for patient safety. Patients should discuss potential risks and benefits with their healthcare provider.

Common side effects include:

  • Gastrointestinal issues like upset stomach, nausea, diarrhea, constipation, gas, and heartburn.
  • Headache, dizziness, or drowsiness.
  • Nervousness or insomnia.

Serious side effects and risks include:

  • Cardiovascular events: NSAIDs can heighten the risk of heart attack or stroke, especially with prolonged use.
  • Gastrointestinal bleeding: Stomach or intestinal bleeding, ulceration, and perforation are risks, particularly in older adults.
  • Kidney damage: Long-term use or use in patients with pre-existing kidney issues can lead to renal injury.
  • Allergic reactions: Severe allergic reactions (anaphylaxis) are possible, especially in those sensitive to aspirin.

Conclusion

Vigafen, a brand name for the NSAID ketoprofen lysine salt, is used for pain and inflammation management. It is distinctly different from vigabatrin, an anti-epileptic drug with a severe vision loss risk. The potential for medication errors due to similar names necessitates careful attention from patients and providers to confirm the correct prescription. Consulting a licensed healthcare professional for clarification is essential for anyone with medication concerns. Understanding the difference between Vigafen and vigabatrin is a vital step for safe and effective treatment.

For more detailed information on ketoprofen, including potential interactions and precautions, consult authoritative sources such as MedlinePlus.(https://medlineplus.gov/druginfo/meds/a686014.html)

Frequently Asked Questions

No, Vigafen and Vigabatrin are two completely different medications. Vigafen is a brand name for ketoprofen, a non-steroidal anti-inflammatory drug (NSAID) for pain and inflammation. Vigabatrin (brand names like Sabril and Vigafyde) is an anti-epileptic drug used to treat severe seizures.

Vigafen is used for the symptomatic treatment of various inflammatory conditions associated with pain. These include rheumatoid arthritis, osteoarthritis, and other musculoskeletal pains, as well as pain related to dental or ear, nose, and throat issues.

The active substance in Vigafen is ketoprofen lysine salt. It belongs to the class of medications known as non-steroidal anti-inflammatory drugs (NSAIDs).

Common side effects include gastrointestinal issues such as nausea, upset stomach, and indigestion. Other effects may include headache, dizziness, or drowsiness.

It is critically important to know the difference because Vigabatrin carries a boxed warning for permanent vision loss and is subject to a restricted distribution program. Mistaking the anti-inflammatory Vigafen for the anti-epileptic Vigabatrin, or vice versa, could lead to severe health consequences and medication errors.

Yes, as with other NSAIDs, serious risks include an increased chance of heart attack, stroke, or severe gastrointestinal bleeding, particularly with long-term use. It should be used with caution, especially in patients with heart or kidney disease.

No, Vigafen (ketoprofen) does not have the same risk of permanent vision loss as Vigabatrin. While some NSAID side effects can include blurred vision, the severe and irreversible visual field constriction associated with vigabatrin is not a risk of Vigafen.

Vigafen is a powder for oral solution. Specific dosing instructions depend on the condition and the patient. Always follow the instructions provided by your healthcare provider and the product's patient information leaflet.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.